Secretion of thyroid-stimulating hormone (TSH) and luteinizing hormone (LH)/follicle-stimulating hormone (FSH) is frequently impaired in the hypophysitis associated with CTLA-4 inhibitor therapy, along with impairment in adrenocorticotropic hormone (ACTH) secretion [7]. The gene discussed is POMC; the disease is hypophysitis.